Cell culture and transfection
Experiments were carried out in HEK293 cells stably expressing murine DORs or its truncated mutant [24, 25] , with the exception of experimental series requiring co-transfection of wild-type DORs either with dominant negative c-Src (DNM-Src: K295R/Y527F) [26] or dominant negative Rab11 (DNM-Rab11: Rab11S25N) [27] . Cells stably expressing wild-type DORs or truncated DOR mutants (DOR344T) were transfected with 6 g/100 mm petri dish of corresponding DNA using lipofectamine (Invitrogen, Burlington, ON, Canada) as transfection agent, followed by selection with G418 (500 g/ml).
Receptor expression levels in DOR clones was assessed by means of [ 3 H]Naltrindole binding yielding a Bmax of 605 Ϯ 42 fmol/mg protein. Membrane expression of DORs and DOR344T was similar, as verified by ELISA. For transient expression, DORs were co-transfected either with DNMSrc (10 g), DNM-Rab11 (15 g) or the empty vector (pcDNA3) using polyethylenimine as transfection agent. Receptor expression was verified by ELISA so as to obtain similar membrane expression across transfection conditions. Cells were grown and maintained in complete DMEM containing 10% (v/v) foetal bovine serum, 1000 units/ml penicillin, 1 mg/ml streptomycin and 5 mM glutamine, in a humidified atmosphere of 5% CO2 at 37ЊC.

Src knock-down by siRNA
A pool of four desalted, deprotected siRNA oligonucleotide duplexes specifically targeted to human Src (GenBank NM_005417) and bearing UU overhangs were purchased from Dharmacon Research (Lafayette, CO, USA) and introduced into DOR-expressing cells performed with DharmaFECT1 according to manufacturer's specifications. In order to achieve optimal Src, knockdown cells were transfected with increasing concentrations of siRNA (100, 50 and 25 nM) and Src expression subsequently verified by Western blot analysis 48, 64 and 72 hrs after transfection. Non-targeting DNA in equivalent concentrations was used to control for off-target changes in Src expression. 25 nM siRNA and 48 hrs recovery post-transfection produced maximal
Src knock-down, and were therefore chosen for the study.
Immunopurification of FLAG-tagged receptors
This procedure was adapted from a previously described method [23] and was used to assess receptor interaction with endogenous Src or G␣ subunits. Briefly, cells were incubated overnight in serum-free medium and the day of the experiment were exposed to PP2 (20 M) 
or vehicle (DMSO) for 1 hr prior to treatment with DPDPE (1 M) for the indicated periods of time.
In experiments in which PTX was used the toxin (100 ng/mL) was introduced 16 hrs prior to the experiment. After agonist stimulation, the reaction was stopped on ice by washing cells with cold PBS. Cells were then suspended in lysis buffer (5 mM Tris, 3 mM MgCl2, 2 mM EDTA, 1 mM NaF, 1mM Na3VO4, 5 g/ml leupeptine, 5 g/ml soybean trypsin inhibitor and 10 g/ml benzamidine) and homogenized using an ultraturax (IKA, Wilmington, NC, USA). Following a short centrifugation at 1500 rpm, the supernatant was centrifuged at 18 ,500 rpm for 20 min. and the resultant pellet was resuspended in lysis buffer for a second round of centrifugation (18,500 rpm; 20 min. 
SDS-PAGE and Western blotting
SDS-PAGE was performed as previously described [23] 
cAMP accumulation assays
cAMP accumulation assays were carried out according to a previously described protocol [23] . Desensitization of DORs (DES) was achieved by 30- 
Internalization assays
Measurement of surface-expressed FLAG-tagged DORs and quantification of receptor internalization was assessed using an ELISA method adapted from [28, 29] 
Data analysis
Statistical analysis and curve fitting were done using Prism 4 (GraphPad, San Diego, CA, USA).
Results
DORs and Src form a constitutive complex that dissociates upon receptor activation
We have previously shown that Src activity regulates the extent and duration of DOR responsiveness to different ligands [23] . 
right panel). Src participation in DOR desensitization was confirmed by repeating similar experiments in cells co-transfected with DORs and a dominant negative Src mutant (K295R/Y527F; DNM-Src) [26] (Fig. 2B). Transfections were optimized to achieve similar membrane expression of DORs as in the previous experimental series, and DNM-Src levels were titrated to obtain complete inhibition of endogenous Src activity (Inset Fig. 2B). Results confirmed that in cells overexpressing DNM-Src, signalling efficacy of desensitized DORs (DPDPE; 1 M; 30 min.) did not differ from that of the corresponding controls (Fig. 2B, right panel). In contrast, in cells where DORs were co-transfected with the empty vector (pcDNA3) agonist pre-treatment significantly reduced subsequent ability of DPDPE to inhibit cAMP production (Fig. 2B, left panel).
Src inhibitors prevent DOR desensitization without modifying internalization, but maximal protection requires normal sequestration
Internalization contributes to rapid desensitization of DORs [30] and Src activity has been implicated in the sequestration of various GPCRs [31, 32] 
Src contributes to receptor desensitization by interfering with recycling
The fact that optimal sequestration was necessary for Src inhibitors to counter agonist-dependent desensitization suggested that the kinase negatively influenced DOR responsiveness via regulation of a post-endocytic event. Previous studies have demonstrated that a small proportion of internalized DORs are recycled to the membrane, while the bulk of them are rapidly trapped in an endocytic compartment from where they are slowly targeted for lysosomal degradation [19, 38] . Since the functional consequence of this sorting pattern is a reduction in receptor signalling [39, 40] [38, 42] . Results showed that at a concentration that reduced DOR recycling (50 M; Inset Fig. 6A ), monensin abolished PP2-mediated protection from desensitization (Fig. 6A) [27, 43] Fig. 6B ) abolished the protective effect of Src-blockers upon desensitization (Fig. 6B) , confirming that recycling is essential for Src modulation of DOR signalling efficacy. [40, 45] . Recycling is thought to contribute to this recovery by Fig. 7A , ␣i3 spontaneously associated with DORs and was susceptible to modulation by the agonist [49] . In particular, exposure to DPDPE for increasing time periods progressively reduced the amount of G␣i3 recovered with the receptor (Fig. 7A) , but the interaction recovered upon agonist removal (Fig. 7B) . Surprisingly, PP2 did not modify DOR-␣i3 uncoupling during exposure to DPDPE (1 M) , but the Src blocker accelerated the recovery of DOR-␣i3 interaction after agonist removal (Fig. 7B ). [15, 19] . This particular sorting phenotype is encoded in the receptor's primary sequence, which predetermines non-covalent interactions between DORs and lysosomal sorting proteins [18, 22, 50] Fig. 3 [18, 22, 50] . The tyrosine residue within this sequence has been identified as the major target for DOR phosphorylation by Src [54] . Hence [55] , which has been recently shown to participate in GPCR recycling and resensitization [56, 57] [58, 59] , and this property has been recently confirmed for DORs [60] . However, spontaneous association between Src and DORs distinguishes them from other GPCRs whose interaction with the kinase only takes place upon receptor activation [32, [61] [62] [63] . As a matter of fact, DOR activation rapidly disrupts its association with Src, an observation that is highly reminiscent of the way agonist binding causes calmodulin to be released from this receptor [64] 
. To confirm this observation, cells were transfected with a mutant form of Rab11 (DNM-Rab11) in which substitution of Ser 25 by Asn interferes with GTP-binding capacity of this small G protein and inhibits recycling
. Similar to monensin, a decrease in DOR recycling by DNM-Rab11 (Inset
Src activity interferes with the recovery of DOR-G␣ interaction after desensitization
Functional desensitization involves uncoupling of the receptor from the G protein [44] while resensitization requires recovery of a physical and functional interaction between the two proteins
Fig. 3 Src blockers protect from desensitization without modifying DOR internalization. Internalization of surface receptors was measured following incubation with DPDPE (1 µM) for the indicated periods of time. Presence of DORs at cell surface was measured by ELISA as explained in 'experimental procedures'. Results are expressed as a loss of surface receptors (percentage of surface receptors observed before internalization) and represent mean ± S.E.M. of seven independent experiments carried out in triplicate. (A) DOR internalization was assessed in cells stably expressing wild-type DORs, following exposure to PP2 (20 mM; 1 hr) or vehicle. (B) DOR internalization was assessed in transiently transfected cells expressing DOR/pcDNA3 or DOR/DNM-Src. allowing internalized receptors to return to the membrane, and making them available for a new cycle of interaction with their signalling partners [46-48]. Thus, if membrane recycling of DORs is enhanced by interfering with Src function (Fig. 5), Src blockade would be expected to improve recovery of DOR interaction with the ␣ subunit. In order to examine this issue, FLAG-tagged DORs were immunopurified and the amount of G␣ recovered with the receptor was determined by Western blot analysis. As shown in
Discussion
Results obtained in this study indicate that the non-receptor tyrosine kinase Src inhibits DOR recycling and by doing so contributes to the desensitization of this receptor. It is well established that only a discrete portion of internalized DORs normally recycles back to the membrane while the great majority of them is targeted for lysosomal degradation
. By showing that its encoded sorting pattern may be modified by changes in Src activity, our results indicate that post-endocytic sorting of DORs is not irreversibly determined by the primary sequence. Functional significance of DOR regulation by Src is emphasized by the remarkable ability of PP2 and DNM-Src to eliminate
Fig. 4 Normal sequestration is required for Src blockers to optimally prevent desensitization. (A) Internalization of surface receptors by DPDPE (1 µM) was measured in cells stably expressing wild-type DORs that were exposed (sucrose) or not (CTL) to sucrose (0.4 M) as well as in cells stably expressing similar amount of truncated DOR mutants (DOR344T). Internalization assays were performed as in
Fig. 7 Src activity interferes with recovery of DOR-G protein interaction upon agonist removal. (A) Cells stably expressing FLAG-tagged DORs were exposed to DPDPE (1 µM) for the indicated time periods prior to DOR immunopurification. The purification product was then separated by electrophoresis SDS-PAGE and subject to successive Western blot analyses with anti-␣i3 and anti-FLAG antibody. DOR-␣i3 interaction was assessed by calculating the ratio between ai3 and FLAG-immunoreactivity
